It’s easy to see that Jim Biggins, Founder and CEO of Access Vascular, is an entrepreneur at heart. He started business ventures as a teenager and has since strategically steered his career path to strengthen the skills needed to eventually launch his own medical device company in 2015.
But it’s an engineering mind that Jim has employed to navigate the challenges of introducing a groundbreaking new biomaterial into the $4.5 billion global market for vascular access devices.
Access Vascular closed on a $20 million Series B fundraising round led by TVM Capital Life Science in 2021, and in early 2002, the company opened its new 40,000-square foot manufacturing facility outside Boston.